Protocol Ledger

NCT03998319 · Phase III · RECRUITING

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

Interventional Phase III clinical trial protocol NCT03998319 sponsored by University of Sydney in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-10-14 Enrollment: 445 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03998319
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)445 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03998319
Protocol FieldVerified Registry Value
NCT IdentifierNCT03998319
Consolidated Lead SponsorUniversity of Sydney
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment445 participants (ESTIMATED)
Registered Start Date2021-10-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03998319
Hospital Research SiteLocationSite Profile
Royal Prince Alfred HospitalCamperdown, AustraliaOpen Hospital Dossier ->
Concord Repatriation General HospitalConcord, AustraliaOpen Hospital Dossier ->
Liverpool HospitalLiverpool, AustraliaOpen Hospital Dossier ->
Royal Adelaide HospitalAdelaide, AustraliaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI